NVS: Novartis AG
NVS exchange rate has changed by -1.97% for today. During the day, the instrument was traded at a low of 148.02 and at a high of 149.63.
Follow Novartis AG dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
NVS News
- Eli Lilly Snags $7 Billion Cancer Deal To Rival Gilead, J&J, Others
- Will Breyanzi's Strong Uptake Help BMY Offset Generic Competition?
- Big Pharma Deepens AI Ties. What It Means For Novo, Novartis.
- Voyager Therapeutics (VYGR): 'Strong Buy' On Inflection Points For VY7523 In AD For 2026
- Merck Lowered Terns Pharmaceuticals Offer Price After Trial Data Review - Merck & Co (NYSE:MRK), Terns Ph
- Amgen's Thyroid Eye Disease Data Rocks Rival Viridian, Makes It The Better Buy (AMGN)
- Pharma, Biotech Giants Ramp Up M&A in Q1 to Boost Pipelines
- AZN, NVO, NVS: What Does Trump’s New 100% Tariff Mean for Pharma Giants? - TipRanks.com
- SRRK Stock Jumps on Resubmission of FDA Filing for SMA Drug
- SRRK Stock Jumps on Resubmission of FDA Filing for SMA Drug
- VYMI vs. VIG vs. VYM: Which Vanguard Dividend ETF Pays You Most? - TipRanks.com
- TEVA's Prolia Biosimilar Gets FDA Nod, Xolair Filing Accepted
- Biogen Secures FDA Nod for Higher Dose of SMA Drug Spinraza
- Incyte Reports Strong 54-Week Data From Late-Stage Skin Disorder Study
- Healthcare ETFs in Spotlight Amid Eli Lily's $2.8B AI Drug Move
- Novartis Bolsters Immunology Pipeline With Excellergy Deal
- Can Gilead's Recent Acquisitions Strengthen Its Long-Term Growth Outlook?
- Novartis Agrees Up to $2B Excellergy Deal Amid Generic Pressure
- Novartis (NVS) Stock Falls on $2B Excellergy Acquisition to Expand Allergy Portfolio - TipRanks.com
- Novartis Expands Pipeline With $2 Billion Biotech Deal
- Cancer Stocks to Buy as Innovation Reshapes Global Oncology Market
- KPTI Stock Down on Mixed Phase III Myelofibrosis Combo Study Data
- Sarepta Surges As It Takes On Novartis' $12 Billion Muscular Dystrophy Buyout
- Merck Nears $6 Billion Deal To Buy Terns Pharma: Report - Merck & Co (NYSE:MRK), Novartis (NYSE:NVS)
Frequently Asked Questions
What is NVS stock price today?
Novartis AG stock is priced at 148.07 today. It trades within 148.02 - 149.63, yesterday's close was 151.05, and trading volume reached 3043. The live price chart of NVS shows these updates.
Does Novartis AG stock pay dividends?
Novartis AG is currently valued at 148.07. Dividend policy depends on the company, while investors also watch 31.50% and USD. View the chart live to track NVS movements.
How to buy NVS stock?
You can buy Novartis AG shares at the current price of 148.07. Orders are usually placed near 148.07 or 148.37, while 3043 and -0.97% show market activity. Follow NVS updates on the live chart today.
How to invest into NVS stock?
Investing in Novartis AG involves considering the yearly range 104.93 - 170.46 and current price 148.07. Many compare -4.25% and 20.32% before placing orders at 148.07 or 148.37. Explore the NVS price chart live with daily changes.
What are Novartis AG stock highest prices?
The highest price of Novartis AG in the past year was 170.46. Within 104.93 - 170.46, the stock fluctuated notably, and comparing with 151.05 helps spot resistance levels. Track Novartis AG performance using the live chart.
What are Novartis AG stock lowest prices?
The lowest price of Novartis AG (NVS) over the year was 104.93. Comparing it with the current 148.07 and 104.93 - 170.46 shows potential long-term entry points. Watch NVS moves on the chart live for more details.
When did NVS stock split?
Novartis AG has gone through stock splits historically. These changes are visible in , 151.05, and 31.50% after corporate actions.
- Previous Close
- 151.05
- Open
- 149.52
- Bid
- 148.07
- Ask
- 148.37
- Low
- 148.02
- High
- 149.63
- Volume
- 3.043 K
- Daily Change
- -1.97%
- Month Change
- -4.25%
- 6 Months Change
- 20.32%
- Year Change
- 31.50%
- Act
- 1.7%
- Fcst
- 0.6%
- Prev
- 0.7%
- Act
- 1.9%
- Fcst
- 0.4%
- Prev
- 0.7%
- Act
- 0.7%
- Fcst
- 0.5%
- Prev
- 0.6%
- Act
- 0.4%
- Fcst
- 0.1%
- Prev
- 0.0%
- Act
- 0.2%
- Fcst
- 0.1%
- Prev
- 0.3%
- Act
- 0.3%
- Fcst
- Prev
- 0.3%
- Act
- 1.5%
- Fcst
- 3.1%
- Prev
- 2.5%
- Act
- Fcst
- Prev